ImmunityBio, Inc. — Director's Dealing 2018

Nov 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-11-27

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-27	Common Stock	S	100000	$1.752	Disposed	189508	Indirect
2018-11-28	Common Stock	S	17140	$1.7576	Disposed	172368	Indirect
2018-11-29	Common Stock	S	34019	$1.6986	Disposed	138349	Indirect

Footnotes

F1: Represents the weighted average share price of an aggregate total of 100,000 shares sold in the price range of $1.75 to $1.7768 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Represents the weighted average share price of an aggregate total of 17,140 shares sold in the price range of $1.75 to $1.78 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 34,019 shares sold in the price range of $1.659 to $1.705 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.